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Abstract
                                                                          
Osteoporosis is the most common metabolic
disease with significant impact on the morbid-
ity and mortality of affected patients.
Osteoporosis has a significant impact on the
economy worldwide. The aim of this study was
to find out whether heel ultrasound is as good
as central bone densitometry scanning in diag-
nosing osteoporosis in patients who are at
high risk of osteoporosis. This was a prospec-
tive study of patients comparing heel ultra-
sound to central bone densitometry scanning
(dual X-ray absorptiometry, DEXA) in patients.
The recruited patients attended for a DEXA
scan of the left hip and lumbar spine. All sub-
jects had an ultrasound of the left heel using
the quantitative heel ultrasound machine. The
results of DEXA scan were blinded from the
results of ultrasound and vice versa. There
were 59 patients who took part in the study, 12
men and 47 women. The mean age was 66
years (SD 11.9) and mean weight was 62.5 kg
(SD 10.7). The sensitivity and specificity of the
ultrasound heel test to predict osteoporosis
were 53% (95%CI: 29-77) and 86% (95%CI: 75-
96) respectively. Specificity for predicting bone
mineral density (BMD)-defined osteoporosis
was high (86%), but sensitivity was low (53%).
A heel ultrasound result in the osteoporotic
range was highly predictive of BMD-defined
osteoporosis. A positive ultrasound heel test in
high risk patients is more useful in ruling in
osteoporosis than a negative test to rule out
osteoporosis.
Introduction
Osteoporosis is the most common metabolic
disease with significant impact on the morbid-
ity and mortality of affected patients.1
Osteoporosis defined by the World Health
Organization is a condition in which bone
mineral density is less than 2.5 standard devi-
ation below the average density in gender
matched young adults.2 It affects both men and
women at different stages of life, as a conse-
quence of interaction of lifetime behavioural
and genetic factors. Osteoporosis has a signif-
icant impact on the economy worldwide. In the
UK, it is estimated that osteoporosis is costing
the Government about five million pounds
daily.3 In the United States, the spending on
osteoporosis is about seventeen billion dollars
annually.4Objective
The aim of this study was to find out
whether heel ultrasound is as good as central
bone densitometry scanning in diagnosing
osteoporosis in patients who are at high risk of
osteoporosis. Previous studies mainly com-
pared heel ultrasound and central bone densit-
ometry scanning (DEXA) in screening purpos-
es, and inclusion of high risk patients for
osteoporosis to our knowledge, has not been
done previously.
Materials and Methods 
This was a prospective study of patients
comparing heel ultrasound to central bone
DEXA in patients who presented to the
Accident & Emergency Department of
Birmingham Heartlands Hospital NHS Trust
(now called the Heart Of England NHS
Foundation Trust), with a low trauma fracture. 
Patients were recruited from the Accident
and Emergency Department of Birmingham
Heartlands Hospital, who presented with low
trauma fractures over an eight month period.
The recruited patients attended for a DEXA
scan of the left hip and lumbar spine at Solihull
Hospital. The test results are computer gener-
ated and analyzed using WHO criteria for the
diagnosis of osteoporosis. All subjects had an
ultrasound of the left heel using the
Quantitative Heel Ultrasound machine (QUS-
2). The results of DEXA scan were blinded from
the results of ultrasound and vice versa. The
accuracy was presented as sensitivity, speci-
ficity, predictive value and likelihood ratio. I
have also estimated post-test probability of
having osteoporosis for the study population
depending on whether the test result was pos-
itive or negative.
Results
There were 59 patients who took part in the
study, 12 men and 47 women. The mean age
was 66 years (SD 11.9) and mean weight was
62.5 kg (SD 10.7). Of the 59 patients, 17 (28%)
had osteoporosis (Table 1). The sensitivity and
specificity of the ultrasound heel test to predict
osteoporosis were 53% (95%CI: 29-77) and
86% (95%CI: 75-96) respectively. The positive
and negative predictive values were 60%
(95%CI: 35-85) and 82% (95%CI: 70-93). The
likelihood ratios for positive and negative test
results were 3.7 (95%CI: 1.6-8.8) and 0.55
(95%CI: 0.33-0.92) respectively (Tables 2 and
3). A positive ultrasound heel test raised the
pre-test probability of 28% to a post-test proba-
bility of 60%. A negative ultrasound heel test
lowered the pre-test probability from 28% to a
post-test probability of 18%.
Specificity for predicting BMD-defined
osteoporosis was high (86%), but sensitivity
was low (53%). A Heel Ultrasound result in the
osteoporotic range was highly predictive of
BMD-defined osteoporosis. On the other hand
a Heel Ultrasound result in the normal range
(i.e. no osteoporosis) lowered the per-test
probability from 28% to a post-test probability
of 18%. A positive ultrasound heel test in high
risk patients is more useful in ruling in osteo-
porosis than a negative test to rule out osteo-
porosis.
Discussion and Conclusions
Osteoporosis prevalence in developed coun-
tries is very high and is increasing especially
with increasing age and decrease physical
activity.
In the UK, NICE guideline recommend pro-
phylactic use of antiosteoporotic medication in
high risk patients especially with low impact
fractures. The cast and unnecessary intake of
                                                               Orthopedic Reviews 2016; volume 8:6357
Correspondence: Faiz R. Hashmi, Trauma and
Orthopedic Surgery, Warwick Hospital, Larkin
road, Warwickshire CV34 5BW, UK.
Tel.: +44.0797.7268004 - Fax: +44.01926.482651.
E-mail: hashmi@btinternet.com
Key words: Osteoporosis; central bone density;
quantitative ultrasound; bone mineral density. 
Contributions: FRH, acquisition of data, concep-
tion, study design, drafting the article; KOE
acquisition of data, conception, analysis of data,
drafting the article. 
Conflict of interest: the authors declare no poten-
tial conflict of interest.
Received for publication: 9 December 2015.
Accepted for publication: 16 May 2016.
This work is licensed under a Creative Commons
Attribution NonCommercial 4.0 License (CC BY-
NC 4.0).
©Copyright F.R. Hashmi and K.O. Elfandi, 2016
Licensee PAGEPress, Italy
Orthopedic Reviews 2016;8:6357
doi:10.4081/or.2016.6357
[page 62]                                                            [Orthopedic Reviews 2016; 8:6357]
medication in normal population has
increased the financial burden on NHS which
is already struggling.
The use of Quantitative ultrasound in this
high risk group will detect patients with osteo-
porosis who can start medication and the
remaining patients can be discharged safely. 
In the light of the pilot Heel Ultrasound
study, how can one interpret Heel Ultrasound
results?  If a Heel Ultrasound result is normal
or negative for osteoporosis, it becomes more
useful in ruling out osteoporosis as it has a
predictive value of 82% and LR of 0.55 (95%CI:
0.33-0.92). Therefore, if Heel Ultrasound scans
were performed on a population similar to the
pilot study population (28% prevalence of
osteoporosis) as all of them are high risk
patients having presented with low trauma
fractures. Then 15.2% would have a Heel
Ultrasound result in the osteoporotic range
(likely to have osteoporosis) and 61% would
have results in the normal range (osteoporosis
could fairly confidently be ruled out, with a
post-test probability 18%). However, there
would be a degree of uncertainty about the
remaining 13.5%, who would then need a
DEXA scan to identify those with osteoporosis. 
Previous studies of Heel Ultrasound as a
predictor of BMD have generally used conven-
tional sensitivity and specificity analyses only,
not LRs, and have not used the WHO BMD def-
initions. For example, two community-based
cross-sectional studies on 700 post-
menopausal,5 and 1000 peri-menopausal
women respectively,6 found that there was a
40-50% overlap in the number of women in the
lowest quartile of both DEXA and Heel
Ultrasound measurements. Two other studies
found Heel Ultrasound parameters to have a
sensitivity of 65-70% for BMD in the lowest
quartile.7 Only one study other than this pilot
Heel Ultrasound has evaluated QUS in terms
of WHO BMD definitions. It found BUA (Broad
band ultrasound attenuation) and VOS
(Velocity of sound) to have higher sensitivities
of 77% and 69%, respectively for diagnosing
osteoporosis in 100 women aged 60-69 years.8
These higher sensitivities may have been due
to use of higher BUA and VOS cut-off values.
As expected, specificities were lower than in
the above pilot study. 
There is no consensus on what cut-off val-
ues to use with QUS to diagnose osteoporosis.
It was found that changing the cut-off could
achieve higher sensitivity, but only by accept-
ing higher rates of false positives (lower speci-
ficity) and less discriminating likelihood
ratios. 
Quantitative ultrasound has proven to be a
good predictor of fracture risk in several stud-
ies.9 In a large prospective study of 6189 post-
menopausal women over age 65, quantitative
ultrasonography of the calcaneus predicted hip
fracture as accurately as bone densitometry.10
In a larger study of 14,824 patients that includ-
ed younger women as well as men ages 42 to
82 years, quantitative calcaneal ultrasound
also was a good predictor of total and hip frac-
ture risk.11 A third study of 2837 women (463
ages 20 to 39 years and 2374 ages 55 to 79
years) found that quantitative ultrasound of
the calcaneus worked as well as central DEXA
for identification of women at high risk for
osteoporotic vertebral fractures.12 In addition
to predicting fracture risk, other studies have
found that quantitative ultrasound is at least
as good as and possibly better than clinical risk
factors for predicting women at risk for osteo-
porosis.13,14
A major limitation to using quantitative
ultrasound as a screening tool is that the crite-
ria for diagnosing osteoporosis and recom-
mending treatment based upon ultrasound are
not yet well established.15 Furthermore, ultra-
sound cannot reliably be used to follow women
who are treated for osteoporosis because of
limited precision and a slow rate of change of
bone mass at peripheral sites. Thus, most
women with a high risk ultrasound finding will
need a confirmatory DEXA both to determine
the need for treatment based upon well estab-
lished guidelines, and as a baseline for moni-
toring therapy. 
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